Imagen de Portada
Código QR

Challenges to the Development of Emerging Therapies: Hurdles exist across all aspects and phases of drug development and manufacturing.

Publicado en:BioPharm International Vol. 38; no. 3; pp. 6 - 11
Autor principal: CHALLENER, CYNTHIA A.
Formato: Journal Article
Publicado: MJH Life Sciences Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184485595&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184485595
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Apr2025
      vid: 38
      iid: 3
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        184485595
        184485595
      ppf: 6
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Challenges to the Development of Emerging Therapies: Hurdles exist across all aspects and phases of drug development and manufacturing.
      aug:
        au: CHALLENER, CYNTHIA A.
      sug:
        subj:
          Cell Therapy
          Drug Development
          Drug Compounding
          Pharmaceutical Companies
          Biological Products Therapeutic Use
          Automation
          Artificial Intelligence
          Prediction Models
          Decision Making, Clinical
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N